Analyst Ratings for Teva Pharma (TEVA )
TEVA Rating Summary
TEVA Price Target Summary
- Highest: $45.00 (Goldman Sachs)
- Lowest: $40.00 (Jefferies)
- Average: $42.00
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$42.00 (+15.1%)
* Over Last 12-Mos
Rating Score: 4.3 / 10
Percentile Rank: 43%
Avg. $ Target:
$42.00 (+15.1%)
* Over Last 12-Mos
Rating Score: 4.3 / 10
Percentile Rank: 43%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 12/9/2025 | Barclays » Updated 8/12/2026 |
Glen Santangelo | New Coverage | Overweight (N/A) |
42.00 (40.00) |
28.46 (36.50) |
28.25% | Details |
| 12/5/2025 | Scotiabank » Updated 1/29/2026 |
Louise Chen | New Coverage | Sector Outperform (N/A) |
40.00 (35.00) |
27.83 (36.50) |
31.15% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
